IRIS
FERRARI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.191
EU - Europa 1.270
AS - Asia 1.056
Continente sconosciuto - Info sul continente non disponibili 171
SA - Sud America 128
AF - Africa 38
OC - Oceania 1
Totale 5.855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.073
RU - Federazione Russa 854
SG - Singapore 403
CN - Cina 274
IT - Italia 211
VN - Vietnam 142
BD - Bangladesh 91
BR - Brasile 74
GB - Regno Unito 59
FR - Francia 57
CA - Canada 53
HK - Hong Kong 38
DE - Germania 28
IN - India 26
AR - Argentina 25
MX - Messico 17
NL - Olanda 13
IQ - Iraq 12
CO - Colombia 10
ES - Italia 10
ZA - Sudafrica 9
CL - Cile 8
DZ - Algeria 8
JM - Giamaica 8
CR - Costa Rica 7
EE - Estonia 7
ID - Indonesia 7
PL - Polonia 7
SV - El Salvador 6
TT - Trinidad e Tobago 6
JO - Giordania 5
KR - Corea 5
MY - Malesia 5
PH - Filippine 5
TR - Turchia 5
UA - Ucraina 5
HN - Honduras 4
JP - Giappone 4
KE - Kenya 4
PK - Pakistan 4
UY - Uruguay 4
DK - Danimarca 3
EG - Egitto 3
GT - Guatemala 3
IL - Israele 3
MA - Marocco 3
MD - Moldavia 3
NI - Nicaragua 3
OM - Oman 3
PE - Perù 3
SA - Arabia Saudita 3
SC - Seychelles 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
BJ - Benin 2
BS - Bahamas 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
KZ - Kazakistan 2
LB - Libano 2
MK - Macedonia 2
TH - Thailandia 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
AT - Austria 1
AU - Australia 1
AW - Aruba 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
IE - Irlanda 1
IR - Iran 1
LK - Sri Lanka 1
LT - Lituania 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
VI - Stati Uniti Isole Vergini 1
YE - Yemen 1
Totale 5.686
Salva come PNG Salva come JPEG
Città #
Council Bluffs 588
San Jose 386
St Louis 343
Singapore 224
Ashburn 184
Columbus 141
Phoenix 77
New York 68
Chicago 66
Schaumburg 54
Lauterbourg 48
Santa Clara 43
Los Angeles 41
Ho Chi Minh City 40
Hanoi 36
Hong Kong 36
Olathe 36
Moscow 33
Dallas 32
North Bergen 27
Milan 25
Brooklyn 19
Atlanta 17
Beijing 17
Buffalo 16
Denver 16
Houston 16
Rome 16
Las Vegas 15
Boston 14
Philadelphia 14
Falkenstein 13
Naples 13
Orem 13
Guangzhou 11
São Paulo 11
Toronto 11
Florence 10
The Bronx 10
Jacksonville 9
Montreal 9
San Francisco 9
Washington 9
Grants Pass 8
Agrolândia 7
Bologna 7
Chennai 7
Da Nang 7
Newark 7
Amsterdam 6
Baltimore 6
Charlotte 6
Detroit 6
Kingston 6
Louisville 6
San Salvador 6
Shanghai 6
Spoltore 6
The Dalles 6
Yonkers 6
Amman 5
Baghdad 5
Brescia 5
Cape Town 5
Decatur 5
Erbil 5
Hangzhou 5
London 5
Miami 5
Milwaukee 5
Poplar 5
Queens 5
Staten Island 5
Warsaw 5
Brasília 4
Buenos Aires 4
Cleveland 4
Dalian 4
Dayton 4
Frankfurt am Main 4
Fremont 4
Greenville 4
Haiphong 4
Kansas City 4
Montevideo 4
Murfreesboro 4
Oakland 4
Omaha 4
Pisa 4
Qingdao 4
Richmond 4
San Diego 4
Santiago 4
Shenzhen 4
Tampa 4
Tokyo 4
Turin 4
Vercelli 4
Alajuela 3
Alexandria 3
Totale 3.097
Salva come PNG Salva come JPEG
Nome #
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies 83
Adapting foundation models for rapid clinical response: intracerebral hemorrhage segmentation in emergency settings 67
Intracranial Nonstenosing Atherosclerotic Plaques Assessed With Vessel Wall MRI in Patients With Embolic Stroke of Undetermined Source 66
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 65
Role of JNK3 signaling in acute ischemic stroke cerebroprotection: A systematic review 64
c-Jun N-terminal kinase 3 (JNK3) serum levels in ischemic stroke: preliminary findings for a potential biomarker 64
Association between calcification pattern and the presence of intracranial carotid artery vulnerable non-stenosing atherosclerotic plaques in ESUS 63
c-Jun N-terminal kinase 3 serum levels in ischemic stroke: Preliminary findings for a potential biomarker 61
Predictors of intracranial non-stenosing vulnerable atherosclerotic plaques in ESUS: A risk stratification model 61
Aging and cerebral ischemia during postischemic recovery: enzyme activities of Krebs’ cycle, glutamate and related amino acids as a functional proteomics approach to evaluate the responsiveness of ischemic tissue and drug actions 60
Medial intracranial carotid artery calcifications and hematoma expansion in deep intracerebral hemorrhage 59
Apomorphine Subcutaneous Infusion Likely Induced Acute Thrombocytopenia in a Patient with Parkinson's Disease and Motor Fluctuations 59
Cherishing Professional Success and Personal Fulfillment: Resilience as a Pivotal Leadership Competency for Clinical Pharmacologists and Beyond 58
Bioenergetics of Fluoxetine: a functional proteomic study 58
Correlations between acute-phase serum biomarkers and the neurological deficit of ischemic patients at discharge from the Stroke Unit 57
Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients 56
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study 56
Renal function and Neurofilament Light Chain serum concentrations in ischemic stroke 55
A case report of acute thrombocytopenia induced by Apomorphine in a patient with Parkinson's disease with motor fluctuations 55
Emerging therapies for hyperglycemia in acute ischemic stroke: glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors 55
Marcatori sierici e deficit neurologico: correlazioni nei pazienti con ictus ischemico in fase acuta 55
Relationships between serum Neurofilament Light Chain and blood inflammatory markers in acute ischemic stroke patients 54
Case Report: Intensive multidisciplinary motor-cognitive rehabilitation treatment in Gerstmann–Sträussler–Scheinker syndrome 54
Association between calcification pattern and the presence of intracranial carotid artery vulnerable non-stenosing atherosclerotic plaques in ESUS 53
The energy metabolism of cerebral mitochondria obtained from spontaneous hypertensive rats: a proposed experimental model to study the effects of chronic hypertension and of anti-hypertensive drugs 52
Neurofilament light chain serum concentrations and renal functions in acute ischemic stroke patients 52
Il ruolo della concentrazione sierica dei Neurofilamenti a Catena Leggera (Nf-L) e della Proteina Fibrillare Acida della Glia (GFAP) nella valutazione prognostica del paziente con Ictus Ischemico. 52
Acute-phase serum biomarkers and ischemic stroke severity 52
ABSTRACT NUMBER: ESOC2026A1191 LONGITUDINAL CHANGES IN SERUM ENDOTHELIN-1 AND INTERLEUKIN-6 FOLLOWING ACUTE ISCHEMIC STROKE AND REVASCULARIZATION THERAPIES 52
Potential role of sequential vessel wall magnetic resonance imaging in monitoring response to antithrombotic therapy in stroke due to intracranial atherosclerotic disease: a case report. 52
Glutamate metabolism in cerebral mitochondria after ischemia and post-ischemic recovery during aging: relationships with brain energy metabolism 51
Stress hyperglycemia and early neurologic deterioration in diabetic and non-diabetic patients with intracerebral hemorrhage 51
Warnings and drawbacks for antipsychotic and mood disorder drug prescriptions in the elderly 51
Effect of CDP-Choline on age-dependent modifications of energy and glutamate-linked enzyme activities in synaptic and non-synaptic mitochondria from rat cerebral cortex 50
Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects 50
Acute-phase serum biomarkers and ischemic stroke severity 50
ATP-ases of synaptic plasma membranes in striatum: enzymatic systems for synapses functionality by in vivo administration of L-acetylcarnitine in relation to Parkinson's disease 49
The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence 49
Characterization of a panel of serum biomarkers to define functional outcome in ischemic stroke patients: focus on inflammation 49
Antidepressants and cerebral energy metabolism: new functional proteomic insights. 49
Post-stroke depression: mechanisms and pharmacological treatment 49
Physiopathology and pharmacology of post-stroke depression: from preclinical evidence to patients’ treatment. 48
Fatty-acid Binding Protein-2 (FABP2) serum concentrations and blood lipid profile in ischemic stroke patients 48
Endothelin-1 in embolic stroke of undetermined source patients with complicated non-stenosing intracranial atherosclerotic plaques 48
Secondary stroke prevention in intracranial atherosclerosis guided by sequential vessel wall imaging: a case series 48
Secondary stroke prevention in intracranial atherosclerosis guided by sequential vessel wall imaging: a case series 48
Bioenergetic characterization of lymphocytes from stroke patients 48
Hyperglycemia in acute ischemic stroke: Physiopathological and therapeutic complexity 47
Renal function and Neurofilament Light Chain serum concentrations in ischemic stroke 47
Bioenergetics of lymphocytes as biomarkers of ischemic stroke patients during aging 47
Beyond glycemic control: Uncovering the neuroprotective role of GLP-1 receptor agonists 47
Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing 47
Caratterizzazione di un pannello di biomarcatori sierici per definire l’outcome funzionale dei pazienti con ictus ischemico focalizzato sul processo infiammatorio 47
Effects of Chronic Hypertension on the Energy Metabolism of Cerebral Cortex Mitochondria in Normotensive and in Spontaneously Hypertensive Rats During Aging 46
Endothelin-1 in embolic stroke of undetermined source patients with complicated non-stenosing intracranial atherosclerotic plaques 46
Relationships between serum Neurofilament Light Chain and blood inflammatory markers in acute ischemic stroke patients 46
Correlation of Neurofilament Light Chain serum concentrations with renal function in acute ischemic stroke patients 46
Stress hyperglycemia indexes and early neurological deterioration in spontaneous intracerebral hemorrhage 46
Intracranial carotid artery calcification morphology differs in patients with lacunar and nonlacunar acute ischemic strokes 45
Predictors of intracranial non-stenosing vulnerable atherosclerotic plaques in ESUS: A risk stratification model 45
Potential role of sequential vessel wall magnetic resonance imaging in monitoring response to antithrombotic therapy in stroke due to intracranial atherosclerotic disease: a case report 45
I biomarcatori sierici originati dall’unità neurovascolare nel monitoraggio del paziente con ictus ischemico: ruolo dei neurofilamenti a catena leggera. 44
Ruolo prognostico degli indici sistemici di infiammazione nell’emorragia intraparenchimale spontanea. 44
Acute amnestic syndrome in fornix lesions: a systematic review of reported cases with a focus on differential diagnosis 43
Spasmi tonici involontari di un arto da ischemia lacunare pontina: una rara manifestazione clinica d’esordio. 43
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study. 43
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study 43
Brain Bioenergetics in Chronic Hypertension: Risk Factor for Acute Ischemic Stroke 42
Stress hyperglycemia and early neurologic deterioration in diabetic and non-diabetic patients with intracerebral hemorrhage 42
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study 42
Lymphocytes bioenergetics after stroke: a functional proteomic study 41
Prevention of Acute and recurrent stroke by anti-hypertensives: interaction with thrombolysis. 41
Valutazione delle concentrazioni sieriche di Endotelina-1 in pazienti con ictus ischemico acuto sottoposti a procedure di rivascolarizzazione. 41
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study 40
I neurofilamenti a catena leggera nella valutazione prognostica del paziente con ictus ischemico acuto. 40
Bioenergetics of lymphocytes as potential biomarker in Alzheimer’s Disease: a functional proteomic study 40
The role of the serum biomarkers NF-L and GFAP in predicting ischemic stroke patients’ outcome. 40
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke 40
Bioenergetic characterization of lymphocytes from stroke patients 40
Bioenergetic effects of Clonidine on functional proteomics 40
Neurofilament light chain serum concentrations and renal functions in acute ischemic stroke patients. 39
Action of some antidepressants on mitochondrial metabolism of rat cerebral cortex 39
Cerebral ischemia and peripheral energy dysfunction in lymphocytes 39
Energy Metabolism of Synaptosomes from Different Neuronal Systems of Rat Cerebellum During Aging: A Functional Proteomic Characterization 38
Use of cangrelor in cervical and intracranial stenting for the treatment of acute ischemic stroke: A real life single-center experience 38
Functional proteomics of synaptic plasma membrane ATP-ases of rat hippocampus: Effect of l-acetylcarnitine and relationships with Dementia and Depression pathophysiology 38
Energy metabolism of cerebral mitochondria during aging, ischemia and post-ischemic recovery assessed by functional proteomics of enzymes 38
Bioenergetics of Desipramine: a Functional Proteomic Study 37
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 37
Effetto della Somministrazione Acuta di Clonidina sul Metabolismo Energetico Cerebrale. 37
Functional proteomics as marker for neurological and psychiatric disorders: the first application to dementia for an immediate future 37
Functional proteomics related to energy metabolism of synaptosomes from different neuronal systems of rat hippocampus during aging 37
Selective effects of L-acetylcarnitine on energy-utilizing ATPases of synapses derived from hippocampal sub-fields. 37
Neuroprotection for ischaemic stroke: current status and challenges 36
Lymphocyte bioenergetics in ischemic stroke patients during aging 36
Brain bioenergetics linking preclinical to clinical studies on physiopathology and treatment of affective disorders. 36
Emerging therapies for hyperglycemia in acute ischemic stroke: glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors. 35
Effect of in vivo L-acetylcarnitine administration on ATP-ases enzyme systems of synaptic plasma membranes from rat cerebral cortex 35
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 35
I farmaci incretinici nella terapia dell’iperglicemia nell’ictus ischemico acuto. 35
Totale 4.761
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 0 1 4 0 0 1
2024/202514 0 0 2 0 0 2 2 1 3 1 1 2
2025/20263.757 0 2 5 3 309 105 815 883 334 761 270 270
2026/20272.078 530 508 439 601 0 0 0 0 0 0 0 0
Totale 5.855